Home health telehealth update
May 2022Important Notices
"As you know, home health services have been approved for coverage via telehealth since the onset of the COVID-19 pandemic. Based on the usage and success of home health telehealth, UPMC Health Plan has expanded the option as a permanent telehealth service when appropriate. Effective April 1, 2022, UPMC Health Plan updated the Telehealth – MP.148 policy to include home health services as a telehealth option for members as indicated in the policy. This update is a result of a collaboration between many UPMC Health Plan departments. Services covered by the policy include observation, training or education in skilled nursing, medical social work, physical therapy, occupational therapy, speech therapy, and home health aid. A telehealth visit must include audio and video components.
Home health telehealth has successfully assisted home health agencies with current staff shortages and allows members to conveniently access services in the comfort of their home in a timely and effective manner."
Home health telehealth has successfully assisted home health agencies with current staff shortages and allows members to conveniently access services in the comfort of their home in a timely and effective manner."
Recent Announcements
Clinical workflow changes through Epic®
Changes are coming for network providers that utilize Provider OnLine to submit specific information to UPMC Health Plan. Select activities that were previously completed in Provider OnLine will now transition to UPMC Health Plan Tapestry Link.Sep. 2026Important Notices
CME Webinar: Lifestyle Medicine in Practice: Evidence‑Based Strategies for Chronic Disease Care
Please join us for a live, CME-accredited webinar on Wednesday, Sept. 23 from noon to 1 p.m., that will provide an overview on lifestyle medicine. Participants will learn how to integrate six core domains—nutrition, physical activity, sleep, stress management, avoidance of risky substances, and social connection—into routine care using practical tools such as brief counseling, motivational interviewing, and team-based strategies.Sep. 2026Education/Webinars
Voluntary nationwide recall: Thyroid (Vitruvias – August 2026)
Vitruvias Therapeutics Inc. is recalling one lot, lot 504950, of Thyroid Tablets, USP 30 mg. Thyroid Tablet is used to treat hypothyroidism (underactive thyroid).Sep. 2026Pharmacy Updates